Phase 2, Double-blind, Randomized, Controlled Multi-center Clinical Trial of the Safety and Efficacy of Transplanted Fetal Porcine Cells in Patients With Parkinson's Disease.
PHASE2CompletedINTERVENTIONAL
Timeline
Start Date
August 31, 1997
Study Completion Date
January 31, 2001
Conditions
Parkinson's Disease
Interventions
DRUG
Fetal porcine cells, Neurocell-PD
Trial Locations (1)
33606
PD and Movement Disorders, University of South Florida, Tampa
All Listed Sponsors
collaborator
Diacrin/Genzyme Corporation LLC
INDUSTRY
lead
Genzyme, a Sanofi Company
INDUSTRY
NCT00226460 - Phase 2, Double-blind, Randomized, Controlled Multi-center Clinical Trial of the Safety and Efficacy of Transplanted Fetal Porcine Cells in Patients With Parkinson's Disease. | Biotech Hunter | Biotech Hunter